September 13, 2020 The Critical Path Institute: 15 Years of Impact A catalyst in the development of new tools and approaches to advance regulatory science and medical product developm
September 13, 2020 Drug Development and Regulation in the Age of Precision Medicine An introduction and overview of the Critical Path Institute and University of Arizona collaboration and the regulatory sci
September 13, 2020 New Uses for Existing Drugs: Applications for COVID-19 and Valley Fever What is drug repurposing and why is it important? Learn more about the CURE ID web-based app made possible by the National Center
September 13, 2020 How Math, Statistics, and Artificial Intelligence Can be Used to Develop Treatments for Major Diseases: Quantitative Medicine at the Critical Path Institute This presentation focuses on the bridge between a person’s ultimate health in light of being affected by a debilitating disease,
September 6, 2020 Webinar: FDA Drug Topics: CURE ID: Capturing Clinician’s Experiences Repurposing Drugs to Inform Future Studies in the Era of COVID-19 This new webinar from the Center for Drug Evaluation (CDER), Division of Drug Information (DDI) is now available at:
August 25, 2020 Biomarkers of Crohn’s Disease to Support the Development of New Therapeutic Interventions C-Path’s Crohn's Disease Biomarkers Pre-Consortium funded by The Helmsley Charitable Trust is proud to announce its...
August 16, 2020 Remote Digital Monitoring for Medical Product Development Izmailova ES, Wagner JA, Ammour N, Amondikar N, Bell‐Vlasov A, Berman S, Bloomfield D, Brady LS, Cai X, Calle RA, Campbell M...
August 14, 2020 Demystifying Submissions of eCOA Documentation for Ethics Review: Are We Making Submissions More Difficult than Necessary?
